2007, Number 02
<< Back Next >>
Ginecol Obstet Mex 2007; 75 (02)
Irregular secretion of prolactin in infertile women with normoprolactinemic galactorrhea
Villanueva DCA, Echavarria SM, Juárez BA
Language: Spanish
References: 22
Page: 73-78
PDF size: 215.90 Kb.
ABSTRACT
Background: Abnormal frequency and pulse amplitud of prolactin secretion in micro and macroprolactinomas has been atributed to a dysfunctional tumoral lactotrope. Previous evidence suggests that non tumoral hyperprolactinemia is caused by a hypothalamic dysfunction. The regularity of prolactin secretion has not been studied with cuantitative methods in patients with normoprolactinemic galactorrhea (NPG) which could be considered an entity that precedes non tumoral and tumoral hyperprolactinemia.
Objective: To analyze the 24-hour prolactin secretion pattern and its secretion regularity in a group of infertile women with normoprolactinemic galatorea.
Patients and methods: A transversal-comparative study was carried out in 6 infertile women with normoprolactinemic galactorrhea and 4 healthy women as controls. The 24 hour prolactin profile, the ratio night time mean concentration/daytime mean concentrattion (NM/DM ratio) and apparent entropy (Ap En, Ap En ratio) were compared in the two groups.
Results: Blunting of the nyctohemeral rythm and nocturn hyperprolactinaemia occurred in patients with normoprolactinemic galactorrhea (NPG). NM/DM ratio was lower in patients with NPG than in controls (1.28 ± 0.25
vs. 1.75 ± 0.05; p= 0.01). Higher irregularity of prolactin secretion was found in patients with NPG (ApEn: 0.853 ± 0.158
vs 0.608 ± 0.171, p=0.04; Ap En ratio: 0.839 ± 0.11
vs 0.661 ± 0.14; p=0.04).
Conclusions: The irregularity of prolactin secretion in patients with NPG is not dependant on the presence of a pituitary tumour which suggests that a hypothalamic dysfunction underlies this condition. An irregular secretion and a higher daily mass production of prolactin in patients with NPG could explain both galactorrhea and infertility.
REFERENCES
Groote Veldman R, van der Berg G, Pincus SM, Frolich M, et al. Increased episodic release and disorderliness of prolactin secretion in both micro- and macroprolactinomas. Eur J Endocrnol 1999;140(3):192-200.
Veldhuis JD, Iranmanesh A, Johnson ML, Lizarralde G. Twenty- four-hour rhytms in plasma concentrations of adenohypophyseal hormones are generated by distinct amplitude and/or frequency modulation of underlying pituitary secretion bursts. J Clin Endocrinol Metab 1990;71(6):1616-23.
De Vane GW, Guzick DS. Bromocriptine therapy in normoprolactinemic women with unexplained infertility and galactorrhea. Fertil Steril 1986;46(6):1026-31.
Imai T, Yasuda K, Miura K. Study on galactorrhea-amenorrhea syndrome (GAS) with special reference to normoprolactinemic GAS. Nippon Naibunpi Gakkai Zasshi 1988;64(1):1-15.
McNeilly AS, Friesen HG. Presence of a nonlactogenic factor in human serum which synergistically enhances prolactinstimulated growth of Nb2 rat lymphoma cells in vitro. J Clin Endocrinol Metab 1985;61(3):408-11.
Yamaguchi M, Aono T, Koike K, Nishikawa Y, et al. Effects of nocturnal hyperprolactinemia on ovarian luteal function and galactorrhea. Eur J Obstet Gynecol Reprod Biol 1991;39(3):187-91.
Ochoa R, Mason M, Fonseca E, Moran C, Zarate A. Distribution of growth hormone isoforms in sera from women with normal ovarian function, galactorrhea and normoprolactinemia. Fertil Steril 1993;60(2):272-5.
Board JA, Storlazzi E, Schneider V. Nocturnal prolactin levels in infertility. Fertil Steril 1981;36(6):720-4.
Aisaka K, Ando S, Kokubo K, Sasaki S, et al. A study on the pathogenesis and treatment of normoprolactinemic galactorrhea syndrome. Nippon Sanka Fujinka Gakkai Zasshi 1985;37(11):2385-92.
Rossmanith WG, Boscher S, Ulrich U, Benz R. Chronobiology of prolactin secretion in women: diurnal and sleep-related variations in the pituitary lactotroph sensitivity. Neuroendocrinology 1993;58(2):263-71.
Frantz G. Prolactin. N Engl J Med 1978;298:201-7.
Veldhuis JD, Johnson ML. Cluster analysis: a simple, versatile and robust algorithm for endocrine pulse detection. Am J Physiol 1986;250:E486-E493.
Ishizuka B, Quigley ME, Yen SSC. Pituitary hormone release in response to food ingestion: Evidence for neuroendocrine signals from gut to brain. J Clin Endocrinol Metab 1983;57:1111-6.
Parker DC, Rossman LG, Vanderlaan EF. Sleep-related, nyctohemeral and briefly episodic variation in human plasma prolactin concentrations. J Clin Endocrinol Metab 1973;36:1119-24.
Sassin JF, Frantz AG, Kapen S, Weitzman ED. The nocturnal rise of human prolactin is dependent on sleep. J Clin Endocrinol Metab 1973;37(3):436-40.
Desir D, Van Cauter E, L’Hermite M, Refetoff S, et al. Effects of “Jet Lag” on hormonal patterns. III. Demonstration of an intrinsic circadian rhytmicity in plasma prolactin. J Clin Endocrinol Metab 1982;55:849-57.
Malarkey WB, Beck P. Twenty-four-hour prolactin profiles in normal and disease states: Failure of thyroxine to modify prolactin secretion. J Clin Endocrinol Metab 1973;40:708-12.
Quigley ME, Judd SJ, Gilliland GB, Yen SSC. Effects of a dopamine antagonist on the release of gonadotropin and prolactin in normal women and women with hyperprolactinemic anovulation. J Clin Endocrinol Metab 1979,48:718-20.
Rand T, Kink E, Sator M, Schneider B, et al. MRI of microadenomas in patients with hyperprolactinaemia. Neuroradiology 1996;38:744-6.
Forsbach G, Soria J, Canales ES, Guzman V, et al. A gonadotropic responsiveness to clomiphene, LRH, estradiol and bromocriptine in galactorrheic women. Obstet Gynecol 1977;50:139-44.
Sauder E, Frager G, Case GD, Kelch RP, Marshall JC. Abnormal patterns of pulsatile luteinizing hormone secretion in women with hyperprolactinemia and amenorrhea: Responses to bromocriptine. J Clin Endocrinol Metab 1984;59:941-8.
Petraglia F, De Leo V, Nappi C, Facchinetti F, et al. A Differences in the opioid control of luteinizing hormone secretion between pathological and iatrogenic hyperprolactinemic states. J Clin Endocrinol Metab 1987;64:508-12.